The trouble is, until it has passed a double-blind test, it's basically hearsay. We have those tests because even good researchers working with seemingly promis

The trouble is, until it has passed a double-blind test, it's basically hearsay. We have those tests because even good researchers working with seemingly promising drugs can be fooled by optimism or other biases.